Hair loss prevention by scalp cooling device in early breast cancer patients: the Poliambulanza experience von Prochilo, T, Aroldi, F, Huscher, A, Andreis, F, Zaina, E, Pomentale, B, Pedrali, C, Zanotti, L, Zaniboni, A

Volltext

Dignity Therapy: a new psychoterapeutic approach for people facing advanced disease von Andreis, F., Gadaldi, E., Meriggi, F., Mirandola, M., Rota, L., Abeni, C., Bertocchi, P., Aroldi, F., Prochilo, T., Di Biasi, B., Ogliosi, C., Libertini, M., Noventa, S., Zaniboni, A.

Volltext

566TiP A first-in-human study of NUC-7738, a ProTide transformation of 3’-deoxyadenosine, in patients with advanced solid tumours (NuTide:701) von Blagden, S., Haris, N.M., Boh, Z., Kazmi, F., Aroldi, F., Myers, M., Symeonides, S.N., Plummer, R.

Volltext

600TiP A first-in-human study of, NUC-7738, a 3'-dA phosphoramidate, in patients with advanced solid tumours (NuTide:701) von Symeonides, S., Aroldi, F., Harris, N. Md, Kestenbaumum, S., Plummer, R., Blagden, S.

Volltext

464P Pharmacokinetic analysis of NUC-3373 with and without leucovorin in patients with previously treated metastatic colorectal cancer (NuTide:302 study) von Graham, J., Ciombor, K.K., Aroldi, F., Rodgers, L.J., Coveler, A., Berlin, J., Blagden, S., Evans, J.

Volltext

1446P Preliminary efficacy and safety of rilvegostomig (AZD2936), a bispecific antibody targeting PD-1 and TIGIT, in checkpoint inhibitor (CPI)-pretreated advanced/metastatic non-s... von Brandão, M., Hiltermann, J.T.J.N., Wauters, E., Solomon, B.J., Castanon Alvarez, E., Felip, E., Gort, E.H., Izumi, H., Kim, D-W., Paz-Ares, L., Rohrberg, K.S., Steinbusch, L., Yoshida, T., Chen, H., Colebrook, S., Achour, I., Origuchi, M., Aroldi, F., Cho, B.C.

Volltext

549P Results of a first-in-human study of the ProTide thymidylate synthase inhibitor NUC-3373, in patients with advanced solid tumours (NuTide:301) von Spiliopoulou, P., Kazmi, F., Aroldi, F., Holmes, J., Graham, J., Holmes, T., Lord, S., Veal, G., Qi, C., Coyle, V.M., Evans, T.R.J., Blagden, S.

Volltext

1093TiP An open-label, multicenter, phase I/II clinical trial of RP1 as a single agent and in combination with nivolumab in patients with solid tumors [IGNYTE] von Aroldi, F., Middleton, M.R., Sacco, J.J., Milhem, M.M., Curti, B.D., VanderWalde, A.M., Baum, S.L., Samson, A., Chesney, J., Niu, J., Rhodes, T.D., Bowles, T.L., Olsson-Brown, A., Laux, D.E., Bommareddy, P.K., Menezes, L., Samakoglu, S., Pirzkall, A., Coffin, R.S., Harrington, K.J.

Volltext

Chemotherapy rechallenge after regorafenib treatment in metastatic colorectal cancer. Still hope after the last hope? von Aroldi, F., Bertocchi, P., Prochilo, T., Rota, L., Rizzi, A., Meriggi, F., Di Biasi, B., Abeni, C., Ogliosi, C., Beretta, G.D., Zaniboni, A.

Volltext

Yoga project in Oncology: observational study of the Yoga effects in cancer patient. The Poliambulanza experience von Andreis, F., Liborio, N., Meriggi, F., Codignola, C., Anna, R., Bertocchi, P., Aroldi, F., Abeni, C., Ogliosi, C., Rota, L., Prochilo, T., Di Biasi, B., Mirandola, M., Zaniboni, A.

Volltext

Metformin impact on progression-free survival in diabetic patients with advanced pancreatic neuroendocrine tumors (pNET) receiving everolimus and/or somatostatin analogues. The PRI... von Pusceddu, S., Marconcini, R., Spada, F., Massironi, S., Bongiovanni, A., Brizzi, M.P., Brighi, N., Colao, A., Giuffrida, D., De Fave, Glle, Cingarlini, S., Aroldi, F., Antonuzzo, L., Berardi, R., Catena, L., de divitis, C., Ermacora, P., Di Maio, M., Buzzoni, R., de Braud, F.

Volltext

Single-Agent or Doublets As Second-Line Chemotherapy After Folfirinox in Patients with Locally Advanced or Metastatic Pancreatic Cancer von Pellei, C., Bittoni, A., Andrikou, K., Lanese, A., Santoni, M., Conti, A., Aroldi, F., Delcuratolo, S., Russano, M., Vaccaro, V., Silvestris, N., Milella, M., Santini, D., Zaniboni, A., Cascinu, S.

Volltext

703PWHO SHOULD RECEIVE FIRST-LINE FOLFIRINOX? PROGNOSTIC FACTORS IN LOCALLY ADVANCED OR METASTATIC PANCREATIC CANCER PATIENTS von Andrikou, K., Bittoni, A., Lanese, A., Santoni, M., Pellei, C., Conti, A., Aroldi, F., Brunetti, A., Russano, M., Vaccaro, V., Silvestris, N., Milella, M., Santini, D., Zaniboni, A., Cascinu, S.

Volltext

709PSINGLE-AGENT OR DOUBLETS AS SECOND-LINE CHEMOTHERAPY AFTER FOLFIRINOX IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC PANCREATIC CANCER von Pellei, C., Bittoni, A., Andrikou, K., Lanese, A., Santoni, M., Conti, A., Aroldi, F., Delcuratolo, S., Russano, M., Vaccaro, V., Silvestris, N., Milella, M., Santini, D., Zaniboni, A., Cascinu, S.

Volltext

Who Should Receive First-Line Folfirinox? Prognostic Factors in Locally Advanced or Metastatic Pancreatic Cancer Patients von Andrikou, K., Bittoni, A., Lanese, A., Santoni, M., Pellei, C., Conti, A., Aroldi, F., Brunetti, A., Russano, M., Vaccaro, V., Silvestris, N., Milella, M., Santini, D., Zaniboni, A., Cascinu, S.

Volltext

Integrative multi-omics analysis enables a comprehensive characterization of prostate cancer and unveils metastasis-associated candidate biomarkers von Villa, M., Cazzaniga, G., Bolognesi, M., Crippa, V., Malighetti, F., Aroldi, A., Perri, D., Mazzoleni, F., Bozzini, G., Pagni, F., Piazza, R., Mologni, L., Ramazzotti, D.

Volltext

A0543 - Integrative multi-omics analysis enables a comprehensive characterization of prostate cancer and unveils metastasis-associated candidate biomarkers von Villa, M., Cazzaniga, G., Bolognesi, M., Crippa, V., Malighetti, F., Aroldi, A., Perri, D., Mazzoleni, F., Bozzini, G., Pagni, F., Piazza, R., Mologni, L., Ramazzotti, D.

Volltext

Secondary hyperparathyroidism and thoracic vertebral fractures in heart failure middle-aged patients: a 3-year prospective study von Cellini, M., Piccini, S., Ferrante, G., Carrone, F., Olivetti, R., Cicorella, N., Aroldi, M., Pini, D., Centanni, M., Lania, A. G., Mazziotti, G.

Volltext

Idiopathic erythrocytosis: a germline disease? von Elli, E. M., Mauri, M., D’Aliberti, D., Crespiatico, I., Fontana, D., Redaelli, S., Pelucchi, S., Spinelli, S., Manghisi, B., Cavalca, F., Aroldi, A., Ripamonti, A., Ferrari, S., Palamini, S., Mottadelli, F., Massimino, L., Ramazzotti, D., Cazzaniga, G., Piperno, A., Gambacorti-Passerini, C., Piazza, R.

Volltext

The pre-launch characterization of SIMBIO-SYS/VIHI imaging spectrometer for the BepiColombo mission to Mercury. II. Spectral calibrations von Altieri, F., Filacchione, G., Capaccioni, F., Carli, C., Dami, M., Tommasi, L., Aroldi, G., Borrelli, D., Barbis, A., Baroni, M., Pastorini, G., Ficai Veltroni, I., Mugnuolo, R.

Volltext